NGS market analysis and updates

Next-generation sequencing (NGS) is becoming more affordable and accessible for many, holding great potential to revolutionise healthcare through clinical applications such as non-invasive prenatal testing (NIPT), to detect cancer mutations for disease diagnosis and treatment decisions, genetic testing and infectious disease testing.

Clearstate offers market data, forecasts, and trend predictions to give you the insight on the NGS market which is set to be the fastest-growing IVD market segment in many countries. Our NGS hub is regularly updated to share our findings on this emerging IVD market segment to help prepare your business for the expanding role of NGS in clinical diagnostics.

next-generation sequencing updates by Clearstate

What is next-generation sequencing (NGS)?

Next-generation sequencing (NGS) is a high-throughput method used to obtain the sequence of nucleotides in entire genomes or specific gene regions. Clinical applications of NGS include non-invasive prenatal testing (NIPT), cancer testing, genetic testing and infectious disease testing.

Explore the latest NGS market insights

From market news to analysis, our articles provide concise and up-to-date information about  latest in NGS market developments driving the rapid growth of NGS adoption. Uncover the challenges and opportunities ahead as the technology triggers a shift in healthcare and clinical diagnosis. Understand the impact of the emergence of NGS on the use of other competing diagnostic technologies in molecular and tissue diagnostics, and examine the challenges to implementing NGS at a wider scale in healthcare, including at smaller laboratories.

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.